<SUBMISSION>
<ACCESSION-NUMBER>0001104659-08-023724
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>3
<PERIOD>20080404
<ITEMS>5.02
<ITEMS>9.01
<FILING-DATE>20080410
<DATE-OF-FILING-DATE-CHANGE>20080410
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>CRDENTIA CORP
<CIK>0001073857
<ASSIGNED-SIC>7363
<IRS-NUMBER>760585701
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>000-31152
<FILM-NUMBER>08750589
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>14114 DALLAS PARKWAY
<STREET2>SUITE 600
<CITY>DALLAS
<STATE>TX
<ZIP>75254
<PHONE>972-850-0780
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>14114 DALLAS PARKWAY
<STREET2>SUITE 600
<CITY>DALLAS
<STATE>TX
<ZIP>75254
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>LIFEN INC
<DATE-CHANGED>20001115
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>DIGIVISION INTERNATIONAL LTD
<DATE-CHANGED>20001005
</FORMER-COMPANY>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a08-6716_18k.htm
<DESCRIPTION>CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES
<TEXT>

<html>

<head>





</head>

<body lang="EN-US">

<div style="font-family:Times New Roman;">

<div style="border:none;border-top:double windowtext 6.0pt;padding:0in 0in 0in 0in;">

<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

</div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">UNITED STATES</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Washington, DC&#160; 20549</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman">&nbsp;</font></b></p>

<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">

<hr size="1" width="25%" noshade color="black" align="center">

</font></b></div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman">&nbsp;</font></b></p>

<h2 align="center" style="color:black;font-weight:bold;margin:0in 0in .0001pt;page-break-after:auto;text-align:center;"><b><font size="5" color="black" face="Times New Roman" style="color:windowtext;font-size:18.0pt;">FORM&nbsp;8-K</font></b></h2>

<h2 align="center" style="color:black;font-weight:bold;margin:0in 0in .0001pt;page-break-after:auto;text-align:center;"><b><font size="2" color="black" face="Times New Roman">&nbsp;</font></b></h2>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">CURRENT
REPORT</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">Pursuant
to Section&nbsp;13 or 15(d)&nbsp;of<br>
the Securities Exchange Act of 1934</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of Report (Date of earliest event
reported): <b>April&nbsp;4, 2008</b></font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman">&nbsp;</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">CRDENTIA CORP.</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact name of registrant as specified in its
charter)</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Delaware</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">000-31152</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">76-0585701</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(State or Other Jurisdiction of <br>
  Incorporation)</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Commission<br>
  File Number)</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(I.R.S. Employer<br>
  Identification Number)</font></p>
  </td>
 </tr>
</table>

</div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<h3 align="center" style="color:black;font-weight:bold;margin:0in 0in .0001pt;page-break-after:auto;text-align:center;"><b><font size="2" color="black" face="Times New Roman" style="color:windowtext;font-size:10.0pt;">5001 LBJ Freeway, Suite&nbsp;850<br>
Dallas, Texas 75244</font></b></h3>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address of Principal Executive Offices) (Zip
Code)</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(972) 850-0780</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Registrant&#146;s telephone number, including
area code)</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Former name or former address, if changed
since last report.)</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check the appropriate box below if the Form&nbsp;8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of
the following provisions (<i>see</i> General
Instruction A.2. below):</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font> Written communications
pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font> Soliciting material
pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font> Pre-commencement
communications pursuant to Rule&nbsp;14d-2(b)&nbsp;under the Exchange Act (17
CFR 240.14d-2(b))</p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font> Pre-commencement
communications pursuant to Rule&nbsp;13e-4(c)&nbsp;under the Exchange Act (17
CFR 240.13e-4(c))</p>

<div style="border:none;border-bottom:double windowtext 6.0pt;padding:0in 0in 0in 0in;">

<p align="center" style="border:none;margin:0in 0in .0001pt;padding:0in;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

</div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">

<hr size="3" width="100%" noshade color="#010101" align="left">

</font></b></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\C900109\08-6716-1\task2854667\6716-1-ba.htm',USER='C900109',CD='Apr 11 01:05 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 5.02</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.78%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Departure of Directors or Certain Officers; Election of Directors;
  Appointment of Certain Officers; Compensatory Arrangements of Certain
  Officers</font></b></p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman">&nbsp;</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Appointment of Directors</font></i></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">At
a meeting on April&nbsp;4, 2008, the Board of Directors of Crdentia Corp. (the &#147;Company&#148;)
(i)&nbsp;increased the size of the Board from five directors to seven
directors; and (ii)&nbsp;appointed David A. Jenkins and Raymond J. (Jay) Dunn,
IV to fill the vacancies created thereby.&#160;
On April&nbsp;10, 2008 the Company issued a press release regarding the
new directors.&#160; The press release is
filed with this Current Report on Form&nbsp;8-K as Exhibit&nbsp;99.1.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Transactions with Fatboy Capital, LP</font></i></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr.&nbsp;Jenkins
is the managing member of the general partner of Fatboy Capital, LP (&#147;Fatboy&#148;).&#160; In 2007, Fatboy purchased 5,800,000 shares of
common stock and a warrant to purchase 2,733,333 shares of common stock from
the Company for aggregate consideration of $1,840,000.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In
consideration of advisory services, in October&nbsp;2007 the Company issued a
warrant to FatBoy to purchase up to 1,000,000 shares of common stock at $0.45
per share.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On
January&nbsp;15, 2008, the Company obtained a $1,000,000 loan from FatBoy to
fund working capital needs. The loan was payable upon the earlier of (i)&nbsp;March&nbsp;31,
2008 or (ii)&nbsp;the date of the closing of any refinancing of the Company&#146;s prior
secured indebtedness. The loan bore interest at the rate of eighteen percent
(18%) per annum and interest on past-due principal and past-due interest
accrued at the rate of twenty-four percent (24%) per annum and was payable on
demand. The Company paid FatBoy a five percent (5%) commitment fee for the
extension of the loan. MedCap Partners&nbsp;L.P. unconditionally guaranteed the
Company&#146;s obligations under the loan. The loan was repaid on February&nbsp;22,
2008.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Transactions with Latin Healthcare Investments, LLC</font></i></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr.&nbsp;Dunn
is a cofounder and Managing Director of Latin Healthcare Investments, LLC (&#147;Latin
Healthcare&#148;).&#160; In 2007 Latin Healthcare
purchased 2,500,000 shares of common stock and a warrant to purchase 1,250,000
shares of common stock from the Company for aggregate consideration of $750,000.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In
consideration of advisory services, in October&nbsp;2007 the Company issued a
warrant to Latin Healthcare to purchase up to 225,000 shares of common stock at
$0.45 per share.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Director Option Grants</font></i></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On
April&nbsp;4, 2008, the Board of Directors approved the grant of an option to
purchase 100,000 shares of the Company&#146;s common stock to each of Thomas Herman
and David Jenkins.&#160; The options have an
exercise price of $0.23 per share, the last sale price of the Company&#146;s common
stock as reported on the OTC Bulletin Board on April&nbsp;4, 2008.&#160; The options vest and become exercisable over
two years, with 50% of the shares subject to the options vesting on the first
anniversary of the date of grant and the remaining 50% of the shares subject to
the options vesting on the second anniversary of the date of grant.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Director Restricted Stock Grants</font></i></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On
April&nbsp;4, 2008, the Board of Directors approved the grant of 100,000 restricted
shares of the Company&#146;s common stock to each of Robert Kenneth, William Nydam
and Jay Dunn.&#160; The shares of restricted
stock vest over a two-year period. Assuming continued association with the
Company, the first 50% of the shares shall vest on the first anniversary of the
date of grant and the remaining 50% of the shares shall vest on the second
anniversary of the date of grant.&#160; The
shares are valued at the fair market value of $0.23 per share, the last sale
price of the Company&#146;s common stock as reported on the OTC Bulletin Board on April&nbsp;4,
2008.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>

<div style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">

<hr size="3" width="100%" noshade color="#010101" align="left">

</font></b></div>

</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\C900109\08-6716-1\task2854667\6716-1-ba.htm',USER='C900109',CD='Apr 11 01:05 2008' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Suspension of Annual Director Grant Program</font></i></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On
April&nbsp;4, 2008, the Board indefinitely suspended the Company&#146;s program
pursuant to which (i)&nbsp;non-employee directors were issued 3,333 shares of
common stock (or options to purchase such shares) upon their election to the
Board of Directors, and (ii)&nbsp;non-employee directors were thereafter issued
833 shares of common stock (or options to purchase such shares) in each of the
following two years of their three year term, except for the chairman of the
audit committee, who received an aggregate of 1,666 shares of common stock (or
options to purchase such shares) in each of the following two years.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Chief Executive Officer Compensation</font></i></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On
April&nbsp;4, 2008, the Company&#146;s Board of Directors increased the annual base
compensation of John Kaiser, the Company&#146;s Chief Executive Officer, from
$250,000 to $275,000.&#160; In addition, Mr.&nbsp;Kaiser
was granted 300,000 shares of restricted common stock.&#160; Twenty-five percent (25%) of the restricted
shares shall vest twelve (12) months after the date of grant. One-thirty-sixth
(1/36th) of the remaining unvested shares shall vest at the end of the 13th
month and each month thereafter, such that the shares will be one hundred
percent (100%) vested after forty-eight (48) months of continuous services from
date of grant.&#160; The shares are valued at
the fair market value of $0.23 per share, the last sale price of the Company&#146;s
common stock as reported on the OTC Bulletin Board on April&nbsp;4, 2008.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Chief Financial Officer Compensation</font></i></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On
April&nbsp;4, 2008, the Company&#146;s Board of Directors increased the annual base
compensation of James J.&#160; TerBeest, the
Company&#146;s Chief Financial Officer, from $220,000 to $250,000.&#160; In addition, Mr.&nbsp;TerBeest was granted an
option to purchase 200,000 shares of common stock.&#160; The option has an exercise price of $0.23 per
share, the last sale price of the Company&#146;s common stock as reported on the OTC
Bulletin Board on April&nbsp;4, 2008.&#160;
The option vests with respect to 50% of the shares over four years from
the date of grant based on continued service to Company. The option vests with
respect to the remaining 50% of the shares if the Company completes a debt
financing prior to the end of April&nbsp;2008.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 9.01</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160; </font>Financial Statements and
Exhibits.</b></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman">&nbsp;</font></b></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Exhibits.</i></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><i><font size="2" face="Times New Roman">&nbsp;</font></i></p>

<table border="1" cellspacing="0" cellpadding="0" width="92%" style="border:none;border-collapse:collapse;margin-left:.6in;width:92.0%;">
 <tr>
  <td width="10%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.6%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Exhibit&nbsp;No.</font></b></p>
  </td>
  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.88%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="87%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:87.54%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Description</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="10%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:10.6%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1</font></p>
  </td>
  <td width="1%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:1.88%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="87%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:87.54%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Press
  Release of Crdentia Corp. dated April&nbsp;10, 2008.</font></p>
  </td>
 </tr>
</table>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>

<div style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">

<hr size="3" width="100%" noshade color="#010101" align="left">

</font></b></div>

</div>
<!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\C900109\08-6716-1\task2854667\6716-1-ba.htm',USER='C900109',CD='Apr 11 01:05 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SIGNATURES</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned hereunto duly authorized.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="43%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:43.34%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CRDENTIA
  CORP.</font></p>
  </td>
 </tr>
 <tr>
  <td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.46%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="38%" valign="top" style="padding:0in 0in 0in 0in;width:38.88%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">April&nbsp;10,
  2008</font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.46%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>
  </td>
  <td width="38%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:38.88%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/
  James J. Terbeest</font></p>
  </td>
 </tr>
 <tr>
  <td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.46%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="38%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:38.88%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">James
  J. Terbeest</font></p>
  </td>
 </tr>
 <tr>
  <td width="56%" valign="top" style="padding:0in 0in 0in 0in;width:56.66%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.46%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="38%" valign="top" style="padding:0in 0in 0in 0in;width:38.88%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chief
  Financial Officer</font></p>
  </td>
 </tr>
</table>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>

<div style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">

<hr size="3" width="100%" noshade color="#010101" align="left">

</font></b></div>

</div>
<!-- SEQ.=1,FOLIO='4',FILE='C:\JMS\C900109\08-6716-1\task2854667\6716-1-ba.htm',USER='C900109',CD='Apr 11 01:05 2008' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a08-6716_1ex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>

<html>

<head>





</head>

<body lang="EN-US">

<div style="font-family:Times New Roman;">

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit
99.1</font></b></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="94%" style="border-collapse:collapse;width:94.62%;">
 <tr>
  <td width="341" valign="top" style="padding:0in 0in 0in 0in;width:255.45pt;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For Immediate Release</font></p><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Contact Crdentia Corp.</font></b></p>
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">John Kaiser, CEO</font></p>
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Phone: 972.850.0780</font></p>
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fax: 972.392.2722</font></p>
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">jkaiser@crdentia.com</font></p>
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Jim TerBeest, CFO</font></p>
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Phone: 972.850.0780</font></p>
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fax: 972.392.2722</font></p>
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">jterbeest@crdentia.com</font></p>
  </td>
  <td width="341" valign="top" style="padding:0in 0in 0in 0in;width:255.5pt;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><img width="404" height="122" src="g67161mm01i001.jpg"></font></p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Crdentia Announces Appointments
of David Jenkins and Raymond Dunn to Board of Directors</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company&#146;s Board Expanded to
Seven Members</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">DALLAS, April&nbsp;10, 2008</font></b><font size="2" style="font-size:10.0pt;"> &#150; Crdentia Corp. (OTCBB:CRDT), a leading
healthcare staffing company, today said that its Board of Directors has elected
David Jenkins and Raymond (Jay) Dunn to its Board of Directors, effective
immediately.&#160; This announcement expands
the Company&#146;s Board of Directors to seven members.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">John Kaiser, Crdentia&#146;s
President and Chief Executive Officer, said, &#147;I am delighted David and Jay have
joined Crdentia&#146;s Board of Directors.&#160;
Each has tremendous depth of knowledge, healthcare expertise and public
company experience that now can accrue to the benefit of Crdentia.&#160; With this announcement, the strength of our
board is further enhanced, and we look forward to contributions from David and
Jay as we continue our efforts to execute our strategic initiatives to improve
Crdentia&#146;s operations and profitably grow our business.&#148;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr.&nbsp;Jenkins is
currently the managing member and general partner of FatBoy Capital, LLC, a
shareholder of Crdentia.&nbsp; In addition, Mr.&nbsp;Jenkins is also a Director
of EP MedSystems,&nbsp;Inc. (NASDAQ: EPMD), a medical technology company that
develops, manufactures and markets cardiac rhythm management and
electrophysiology products, which are used to diagnose, monitor, visualize and
treat irregular heartbeats known as arrhythmias.&#160; EP MedSystems,&nbsp;Inc. recently announced
an agreement to be acquired by St. Jude&#146;s Medical,&nbsp;Inc.&#160; Mr.&nbsp;Jenkins has also served as President
and a director of Transneuronix,&nbsp;Inc., a privately-held company engaged in
the development of neuromuscular stimulation devices, until its sale to
Medtronic Inc. in 2005.&#160; He is currently
a director of Inset Technologies,&nbsp;Inc. and Catheter Robotics,&nbsp;Inc.,
both of which are privately held medical device companies.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr.&nbsp;Dunn is
co-founder and Managing Director of the Latin Healthcare Fund (LHF), a
shareholder of Crdentia, and Healthcare Investments International LLC (HII), ,
which are US-based private equity investment groups that invests in healthcare
companies.&#160; LHF and HII are affiliates of
ACON Investments LLC, to identify healthcare investment opportunities in the
U.S.&#160; Mr.&nbsp;Dunn also served on the
Boards of Farmacias Ahumada, the largest pharmacy chain in Latin America and
publicly traded in Chile; and Integramedica, the largest outpatient services
company in Chile.&#160; Prior to LHF and HII, Mr.&nbsp;Dunn
was Senior Investment Officer at Global Environment Fund where he managed the
investment program for Latin America and served on company boards in Argentina,
Chile, Peru and Colombia.&#160; He also
sourced and analyzed investment opportunities in Eastern Europe and the Middle</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\C900109\08-6716-1\task2854745\6716-1-mm-01.htm',USER='C900109',CD='Apr 11 01:33 2008' -->


<br clear="all" style="page-break-before:always;">


<div>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">East.&#160;&#160; Mr.&nbsp;Dunn started his career with Brown
Brothers Harriman&nbsp;&amp; Co. as a banking officer in the Trade and Commodity
Finance Group.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">About
Crdentia Corp.</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Crdentia Corp., one of
the nation&#146;s leading providers of healthcare staffing solutions, is focused on
recruiting talented national and international healthcare professionals to meet
the ever-increasing employment needs of over 2,300 clients. Crdentia is one of
the few companies that can provide quality temporary staff for all healthcare
industry positions including local nurses, travel nurses, allied health, locum
tenens and home care professionals. For more information, visit
http://www.crdentia.com.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Forward
Looking Statements</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Statements
contained in this release that are not historical facts are forward-looking
statements that involve risks and uncertainties.&#160; Among the important factors which could cause
actual results to differ materially from those in the forward-looking
statements include, but are not limited to, those discussed in &#147;Risk Factors&#148;
in the Company&#146;s Forms 10-K, Forms 10-Q, and other filings with the Securities
and Exchange Commission.&#160; Such risk
factors include, but are not limited to, a limited operating history with no
earnings; reliance on the Company&#146;s management team, members of which have
other business interests; the ability to successfully implement the Company&#146;s
business plan; the ability to continue as a going concern; the ability to fund
the Company&#146;s business and acquisition strategy; the growth of the temporary
healthcare professional staffing business; difficulty in managing operations of
acquired businesses; uncertainty in government regulation of the healthcare
industry; and the limited public market for the Company&#146;s common stock.&#160; The actual results that the Company achieves
may differ materially from any forward-looking statements due to such risks and
uncertainties.&#160; Crdentia undertakes no
obligation to revise or update publicly any forward-looking statements for any
reason.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\C900109\08-6716-1\task2854745\6716-1-mm-01.htm',USER='C900109',CD='Apr 11 01:33 2008' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g67161mm01i001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g67161mm01i001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"`!Z`90#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V2BBB@`HH
MHH`**BGN(K=<R-R>@'4UG2^(;2)RKO$A'9YE!_*@+7-:BL;_`(2:Q_Y[6_\`
MW_6C_A)K'_GM;_\`?]:!\K[&S16-_P`)-8_\]K?_`+_K1_PDUC_SV@_[_K0'
M*^QLT54M]3M[C&#MW=#G(/XU;H$%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%([!$9ST49--DECB7,CA1[FJES?6\EO(B/EBN!P:`
M/-_B!XKNH;G^SK24QR.NZ:13RH/11Z5YTWS$LWS$]2>2:[+Q1X8UO4?$5U=6
MMBTL+[=K;U&<*!W-9/\`PA?B+_H&M_W\7_&H=SWL-*C3II)J_J86U?0?E1M7
MT'Y5O#P3XB/_`##R/K(O^-+_`,(1XB_Y\!_W]7_&E8W]O2_F7WF!M7T'Y4;5
M]!^5;DW@[7K>"2>6QVQQJ68^8O`')[UB4%QG&?PNYKZ!XBN]"NU9)&>V)_>P
MDY!'J/0U[MI-X+RS5@VX8!5O52,BOG*O<O!MQ'#H%D96(S;1XXSVJHGF9A3B
MK36YU-%0QW<$IVI*"?0\5-5'E!1110`4444`%%%%`!1110`4444`%%%%`!11
M2,RHC.[!549)/0"@!:*S[77]&OYTM[/5K*XF<$K'%<*[$#D\`UH4`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`5%<S"W@:
M0\D=!ZFI:SM:8K:`CMD_I0!YIXN\=W:7\MEIL@5HSMEN",G/<+V&/6N2/B/7
M&.3JUWD_]-#6<[%W9F.2Q))]325%SZ.GAZ<(V2-'_A(M;_Z"UW_W]-'_``D6
MM_\`06N_^_IK.HI&GLX=D>H>`KVZOM'GDN[B2=Q.5#2-D@;1Q73UR/PW_P"0
M%<?]?)_]!6NNJUL>!B4E6DD4M9_Y`=__`->\G_H)KQ0=*]KUG_D!W_\`U[R?
M^@FO%!TI2._+OAD+7;Z_J-[I_A306LKJ6W+Q88QMC/RBN(KK_%?_`"*7A[_K
ME_[**1U5DG."??\`0I:7XWUFPG4W%PUY#GYHY>N/9NQKV/P_K$6JV,4T3[TD
M3<C'KCN#[BOGJO5OA9([:2%)X6X<#V&`::9RXZA!0YXJS/1:**\W^*_Q$D\,
MVZZ/I,@&IW";GE'/V=#W'^T>WIU]*H\@Z'Q1\0_#OA/,5]=&6[QD6MN-\GX]
ME_$UR-O\3O&'B(EO#'@TO!G"S7#$J?Q^5?UK!^%?PZ3Q!GQ+X@1I[8N?(AD)
M/GL#R[>HS^9S^/N,<:11K'&BHBC"JHP`/0"@#S.37/C!;J97\-:;*HY*(03^
MDF:H0_&^\TV\-IXD\,RVLB_>\IBK#_@#C^M>NUE>(?#.D^*-/:SU6U65<?)(
M!AXSZJW:@!/#?B73?%6E_P!HZ6\C0ARC"1"I5@`2/U'2M:L7PCX<B\*>'+?1
MXIO.$+.QEV[2Y9B<X^A`_"MJ@`HHHH`****`"JNJ?\@F\_ZX/_Z":M55U/\`
MY!-Y_P!<'_\`030!\\?!K_DH]E_URE_]`-?2-?-WP:_Y*/9?]<I?_0#7TC0`
M4444`%%%%`!1110`4444`%%%9GB35VT'PY?ZJD(F:TA,@C+8#$=LT`:=%>7?
M#'Q]K?C/Q1?IJ+Q1VT5KOC@A3"J=X&<GDG'O7J-`''_$GQK-X*T.&XM+9)[J
MZE\N/S,[$P,DG'7Z55^&'CZZ\:V=Y'?VT<5W9E2SP@A'5LXX.<'@UT^O^'=+
M\3::=/U:V$T)8,N#AD8=P1T-1>&_"ND>%+%K32+;RED;=([,6=S[DT`;%%%%
M`!1110`4444`%%%%`!6;KG_'H/\`@7\JTJS=<_X]!_P+^5`T?.QZFM+PY;0W
MGB&RM[F,21228=&Z$8-9IZFM?PG_`,C5IW_77^AK,^FJNU.7H>C_`/"(>'O^
M@5#^;?XT?\(AX>_Z!4/YM_C6S15V1\Y[:I_,_O*MAIMEI<+0V-NL$;-N*KGD
M^O-6J**9#;;NQDL4<\+PRJ&CD4JRGN#U%9/_``B'A[_H%0_FW^-;-%`XSE'X
M78QO^$0\/?\`0*A_-O\`&N>^(L$5MIFF00H$CC=E11V&!Q7=5Q/Q,_X\]/\`
M^NC_`,A2>QU86<I5H\SO_P`,>?5ZI\*O^06?^OEO_017E=>J?"K_`)!9_P"O
MEO\`T$5*W/1QW\$]$EE2"%Y9#A(U+,?0#DU\HW]W=>,/&,D[$F;4KL*F?X0S
M84?@,#\*^F_%DC1>$-9D0X9;&8@_\`-?-_PYC63XA:(K#(^U*?Q&2/Y59X1]
M/:?8P:9IUO86R!(;:-8T`]`,58HHH`****`"N"^(WQ%NO`]Y8PV^GPW:W4;L
M3(Y4J00.WUKO:\1_:`_Y">C?]<)?_0EH`[.;XHV6F^!;#Q!J4*B\OT8PV4+<
ML0Q'4]!P,FL?P!\4-;\8^+O[.GL;.&T\EY6\L,74#&.2<'DCM5;X2^#;75=&
MA\0:[$M\5!@L89AN2*-2<G:>"2V?\FO3;;0M)LM0.H6FFVUO=-'Y32Q1A"5R
M#@X]P*`+]>?^,_BWI?AFZ?3K&`ZEJ"'#JK8CB/H6[GV%:?Q,\3R>%O!T]S;/
MLO+EA;V[=U8@Y;\`"?KBO-O@CX8AU75KO7KZ,3+9$+"'Y!E;DL?<#]3GM0!T
M-GXS^*=\HNX?!]N;9AN"NK(Q'MN<']*W])\>0:[;W^D:E83:1K,=M(6LY_XQ
MM/*'C/\`GK7;5Q7Q2\/C5/"\NJ6N8M2TI3/!.G#!1]]<^A&3]10!Y'\&O^2C
MV7_7*7_T`U](U\W?!K_DH]E_URE_]`->]^*=<3PYX9O]7<!C;1$HIZ,YX4?F
M10!C^,_B1HO@W%O-NN[]EW"UB(RH[%C_``C]?:L:Q\1_$[7+=;RP\.:;8VSC
M=&+QVWL/ID']!7G_`,+-';QAX]FU35B;I;4&ZF,G/F2$_*#[9R<?[-?0]`'F
MS?$_5O#FI16/C?P_]A27[EW:-OC/OCG/X'/M7HEK=V]]:Q75I,DT$RAXY$.0
MP/<5SWQ$T2'7O!&I6[QAI886GA..5=!GCZC(_&N`^`_B.5VO?#L\A:-$^TVX
M)^[R`X'MR#^=`'H?CKQ--X2\,2ZO!;1W#QR(GER$@$,<=JY_PC\4X=9T/5=8
MUN&#3K;3V11L8L7+`\#/4\<`5-\:/^2=7/\`UWB_]"KS7X.^'T\0:_(+X>;I
M^G@7!MVY1Y3\J9'?`W'\*`.JOOBQXKOMTWAWPA.UG_#-/!)(6'K\N`/S-4=*
M^.]_!?"#Q!HT2QAMLC6^Y'C_`.`L3GZ9%>U````#`'0"O(_CMX=MFTRT\00Q
M*ERDP@G91@NI!*D^N",?C0!ZI87UMJ=A!?6<RS6\Z!XW7HP-><_$W6_%D=EK
M&FP>'TET8P8:^W<A2H+'&>QR.E+\"M1DNO"-U92,2+.Z(CSV5@#C\\_G75?$
M/_DGVM_]>C4`>&?#'5/$&E:Q>2^'M'75)WM]LD;'&Q=PYZCOBO;/"&M^*]5N
MKE/$7A]-+BC0&)U;.]L\CJ>U>9?`/_D9]2_Z\O\`V=:]WH`YGQ_XJG\'>'1J
MMO:QW+>>L121B!@@\Y'TJK\.O&MQXWTV\O+BSBM3;S"-5C8MD;<Y.:R_CA_R
M(`_Z_(_Y-6=\`O\`D7-4_P"OL?\`H`H`]5KB_$?Q+T_2-3;1M+LKC6=6!VFV
MME.$/HS8/Z`_A7:5DZ1X<L-&OM1OX$W76HSM--,P&[GHH_V10!P%]XS^*<*&
MY7P;#'`HR5V-(V/<!\_I4OA#XT6VL:E'IFNV2Z?<2ML29&)C+=,,#RO/U_"O
M4*\`^..CVVG>*K6_MD$;7\)>4*,9=3@M]2"/RH`]_HK&\'ZA)JO@_2;Z8DRS
M6B%R>[8P3^8K9H`****`"LW7/^/0?\"_E6E6=K*%[4`=R1^8H`^=3U-:_A/_
M`)&K3O\`KK_0UE2(T<KQN,,K%2/0BM7PG_R-6G?]=?Z&LT?35?X<O1GH]_XM
MT;3;R2SNKATFCQN`B)QD9Z_C5?\`X3OP]_S]R?\`?EJX7QI_R-M]]4_]`%8=
M5=G#3P-*4%)MZH]JTO5[+6;=I[&1I(T;82RE><9[_6KM<C\-_P#D!7'_`%\G
M_P!!6NNIH\RM!0J.*Z$<\T=M;R3RG$<2EV(&<`<FL+_A._#W_/W)_P!^6K4U
MG_D!W_\`U[R?^@FO%!TI-V.K"8:%9-RZ'J__``G?A[_G[D_[\M7,>-]?TW6K
M:S2PG:1HG8N"A7`('K7(44KGH4\'3IR4DWH%>J?"K_D%G_KY;_T$5Y77J_PL
MA==(5R,![AV7W``'\Q0MR<?_``?F=UJEI_:&DWEE_P`_$#Q<_P"TI']:^6/"
M]X=$\8Z;=3C9]EO$\T'^$!L-^F:^L:^=?B_X1DT'Q/)J<$9^P:DQD5@.$D/+
M*?QY'U]JL\(^BOI17$?"WQE%XG\-Q6L\H_M*P01SH3RZCA7'KD=??ZBNWH`*
M***`"O$?V@/^0GHW_7"7_P!"6O;$D20$HZL`2I*G.".HKQ/]H#_D)Z-_UPE_
M]"6@#T+X7`+\-]'`_P">3'_Q]JZRN4^%_P#R3C1O^N3?^AM75T`>._M`S.(-
M$@'W"TSGZC:/ZFMSX&Q+'X#DD`YDO9"?P51_2J?QXTR2Y\-6.HHN19W!5_97
M'7\U`_&F_`75(YO#NH:66'FVUSYH7OM<`?S4_G0!ZI5/6%5M%OE?[IMI`WTV
MFKE<U\1-831/`NJ7+.%>6$P1#N7?Y1C\R?PH`\3^#7_)1[+_`*Y2_P#H!KT_
MXW2,GP_*J>)+N)6^G)_F!7F'P:_Y*/9?]<I?_0#7LWQ-T:37/`6HV\"EYH5$
M\:CJ2AR1^6:`/(_A7;>,94U*3PI<V,&#&+@W0R3][;C@^]>@?8_C#_T$]$_[
MY_\`L*XOX%ZY#8>)+O2IW"#4(AY1)ZNF3C\03^5>]T`>9W.G?%ZXMY()-0T5
MXY4*,`H'!&#_``UG?#?X:>(O"OBU-2U'[+]G$#HWE3;CD].,5Z[29&[;D9`S
MB@#A/C1_R3JY_P"N\7_H5<Y^S_&HL=;D_B,D*_AAO\:Z/XT?\DZN?^N\7_H5
M<]^S_P#\@S6O^NT7\FH`]=K@/C5_R3R;_KYB_G7?UP/QJ_Y)Y-_U\Q?SH`P?
MV?\`_D%:S_UWB_\`037<_$/_`))]K?\`UZ-7#?L__P#(*UG_`*[Q?^@FNX^(
MG_)/M;P,_P"B-0!Y9\`_^1GU+_KR_P#9UKW>O"/@&5'B;4@?O&SX_P"^UKW>
M@#SOXX?\B`/^OR/^35G?`+_D7-4_Z^Q_Z`*T?CA_R(`_Z_(_Y-6=\`O^1<U3
M_K['_H`H`]5KBO$?Q7\,^'KE[/S9;^[0[6BM5#;6]"QXS],UH_$/5+C1_`>J
MWMJY298@B..JEF"Y'N,UY1\#-(L]0\27M]=1K++8PJT(<9VLQ(W?4`?K0!WT
M'C#QOK*!](\$BVB896;4;G9^.W`->5?%6W\2Q:W:2^)[JUEN)H-T4=KGRX5W
M$8Y'K]:^DJ\*^/O_`",6E_\`7F?_`$,T`>H_#O\`Y)]HG_7JO]:Z2N;^'?\`
MR3[1/^O5?ZUTE`!1110`5'/"L\+1MQGH?0U)10!Y7XN\!3W-[)>Z?L2:0YDA
M<X#G^\I_I6)X=\,:W8^(K*XN=/DCBBDR[Y!`&#Z&O;71)%VNH8>A%5;JTMUM
MI&6%0P7((I6.N.,J*'(]4>&>-/\`D;;[ZI_Z`*PZW?&H(\67N1UV'_QP5A5#
M/:H_PH^B/2?AO_R`KC_KY/\`Z"M==7BUCK>J:;$T5E?2V\;-N*H1@GUJQ_PE
MGB#_`*"UQ^8_PJDS@K8*=2HY)K4]7U2*2?2;R&)2\DD#JJCN2#@5Y7_PB'B'
M'_(*F_-?\:9_PE?B`_\`,6N/S'^%)_PE.O?]!:Y_[ZI-W-:&'K44U%K7U)/^
M$0\0_P#0*F_-?\:/^$0\0_\`0*F_-?\`&H_^$IU[_H+7/_?5>Q>$U-YH]K)=
MYED:W1F9^I)'6A*X5Z]:BDW;\3S'2O`&K7<Z_;E%G#GYLL&<^P`_K7K^B:3%
MI=G'%''Y:H@1$_NCW]ZOQV\,1S'&JGU`J2J2L>76Q$ZWQ!5+6-'L->TR;3=2
MMUGMIAAE/4'L0>Q'K5VBF8'@^K?"WQ7X/U8:KX4N)+Q(CF-HB!,@]&7HP^F<
M^E;>G?&N\T]!;^*?#MS#,O#2PH4)^J/C'YUZ[2.BR##J&'HPS0!YK)\=/#I3
M%KINIW$IZ)Y:#]=QK*O/$OQ'\<`VNA:+)HME)PUQ)E&(_P!]@/\`QT9KUR."
M&(YCAC3_`'5`J2@#%\(:%)X:\+V>DS3K/+`&,DJ@@,S,6/7ZUYM\<M)U+4]3
MTC^S]/NKO9#)N\B%GV\CK@5['3%FC>5X5D4R1@%U!Y7/3-`'-_#:":U^'VD0
M7$,D,J1,&CD4JR_.W4&NGIBS1O*\2NIDC`+*#RN>F:?0!4U33+76=,N--OH_
M,M[E"DB^Q[CW'45X5+X7\7_"SQ+_`&KI5O)J%DN5\V)"RR1GJLBCE3[^HXKW
MNZN8K.V>XF)$<8RQ`S1<7$=I;27$I(CC4LQ`SQ0!YU9_&K3KF((WA_5_M>,>
M3#$'!/H#D']*=)HNN^.;@ZQXEL3I^F64;O8Z43N>23:</)_A_P#7SZ.I!&X?
MQ#.:6@#Y]^$NAZO8?$"RN+S2KVWA\J7]Y+;LB_</<BOH*BB@#Q;QU\(]0MM3
M?7/"0+`OYIM8VVO$^<YC/<9YQU':I=*^,6NZ/$MGXG\.W,LT8VF94,3M_O*1
M@GW&*]DJN+^TDN/LPG1I"2`O7)'49Z9H`\Y/Q/\`$6OI]G\*^#[MI7X^T77$
M:>_8?F:Z3P/X>UK1X[Z^\0ZD+W4M1=7DV\K$%!`4'\>P`%=545Q<);1>9)N(
MS@*BEF)]`!UH`XWXO6ES?>`;B"TMY;B5IXL1Q(78_-Z"L/X&Z;?Z98:Q'?V5
MQ:.TT159XF0GANF17I3:A;I,8F<J0RKN*D*6/10>Y]JLT`%<-\8+.ZOO`4L%
MG;2W$IN(B(XD+L>?05W-1W%Q#:6[W%Q*L448W.['`4>IH`\Q^!NFW^F:=K$=
M_97%H[31E5GB9"?E/3(KT;5].CU?1KS393A+N!XB?3<,9IUMJ=C>2M%;W4<D
MBKN*`_,!ZXZX]ZM4#::W/FO1&U[X6^,Q<WVES.B!HI0%.V:,]U;H>@(^G->U
M>&_'MMXHO4M[+1M5BB*%GN;B`)$A';.3DFMU]7L`D;"<2++<_95*C(\S)&T_
MB#5V@&FMS@OC+97=_P"!U@LK6:YE-Y&?+AC+MC#=A6?\#].OM-T'4XK^SGM9
M#=@A9XRA(V#L:]-HH$9WB#1H/$&@WFDW#%8[J(IN`Y4]0?P(!KP&PA\5_"?Q
M.UR^FO+$08W(4F&X3/9AT/`/J/2OHR66."%Y97"1H-S,>@%48O$&D3S""._A
M>0D+L!YR>E`U%O9'"VGQ8U/7(Q!H/@Z^GO'X!E;$*'U+8Z?E7+>//AMXJN;.
M'7IYI-7U29F^V0P#(A7C:L:]2!R#C_Z]>Z=!BB@1P'PTUK5CI&GZ%>>&=0LQ
M:0E'NYUV1\=,`X))KOZ**`"BBB@`HHHH`*1E#J5/0C!I:*`/+_'WA"YO)Q?6
M4>^XC7:\8ZR*.A'N/2O-Y(98G*2Q2(PZJRD$5]*RPQSKMD4,.WM5-M(@8YW-
M^(!I-'?1QLJ<>5JY\Z;6_NG\J-K?W3^5?1/]C0?WC_WR*/[&@_O'_OD4N4V_
MM'^[^/\`P#YVVM_=/Y4;6_NM^5?1/]C0?WC_`-\BC^QH/[Q_[Y%'*']H_P!W
M\?\`@'B7A[PI>ZU=(TD+PV8.9)77&X>B^IKW+2[06EJ%V[<@`+_=`Z"I(;&"
M`A@"S#H6YQ5BFE8XJ^(E6=WL%%%%,YPHHHH`****`"BBB@`K&A%R?$>I?9WA
M4>7#N\Q2>QZ8(K9J-+>))Y)U0"24`.W=L=*`.?GN[NPN]6F)C:?%N@*+@+N)
M&<$]LU>-S=6OG-<M-%;;%"22!&?S"<8`7KG(_&K[V=M(TS/"C&=0LN1G>!T!
M_.H_[,LS"T+0[D<`$,Q;IR.2<C%`&/?7,\FF:Q;S-(RP!-AE`#`-@X..*34$
M;_BH6\UR!;IA21CE#6U_9=ELE7[.")@!)DD[\=,^M++I]I-)*\D(9ID\N3DX
M=?0CO0!FSWEWIDWS3-<HUE)-L90,,F.F!T.:MP-)%8I?7.H,5\GS)"579R,Y
M`QGBK9MH6E24Q@NBE%)[*<9'Z"HDTRSC0QK`/+*E=A)*@'J`.@H`RVU"ZA>[
M599BHL6N(S,BA@PR.`.WL:7[5?+-8VS32S-<Q-,[1JBG@+\JYXQDY]:TETJQ
M0$"`',9B)+$DH?X<D]*DFL;:>...2($1?ZL@D%.,<$<B@!NGM=&V/VQ-L@=@
M,XR5SP3CC.*S8!=Z1);V;F.XLIY2D,J\21%LL,]B.O-;$4,<,8CC7:H[9S4,
M&FVELZO%#M*9V98D)GK@$\?A0!E:7+Y6C641NI_,G+;50`L<$YP2.!WR:CAN
M+F\;2'EGD5S<31L5P-VT.`3QC/%:W]DV(55$&`C%TPQ&TGKCGC/I3XM/M(?+
M\N!5\IV=,?PL>"1^9H`R+::>WL]RSNQ?4S$=X!^7S"#V[T7%Y?K:ZE=K=E?L
M=P5CC"+M*C;P>,]S6S]BMM@3R5VB7SL?[><Y_.AK&U:*:)H5*3L6E7^\3W/Y
M"@#,NKB^>>\CADE$T<D8@CC4%2IQDL<'WZ],"CQB,>#M4&<_Z,W)I+K27N);
MQVMRT\I_<SI+L"#``S@]0?8YK4FLX;NQ:SNU$\4B;)`W1QWS05!\LDSG6>Y@
M\36;WPB>62QE6T:`$>7@*6W@\G/&#T]N:DM]8O)-+\,S-<`R7\B"X.T?.#$S
M'Z<@=*V[;2[*TF::&`"5EV&1B6;;Z9)/'M4$'A_2;:6.2&R56B<R1?,2(V.<
M[1G`ZG@4K&OM(/=?UJ84MW/>6MD\[AFC\0&)<*!A5=P!Q[5H>%HW4:HS7$LO
M_$QF7#D$#!Z]*TQI=B$5!;(%6<W('/$I));ZY)I]O8VUK-/-!%Y;W#;Y,,<,
MWKCIFBPI5(N+2,7[=>WL6M7*7AM1I\KQ0H%4K\B!MSY'.<^W%5K;4-4UB:X*
M7KV*+IT%RB1QJ2LCAB<E@>.!Q6]<:/I]U+)+-;!FE`$HR0),=-P!PWXU,ME;
M+/+.L*B29!'(P_B49P/U-%A^TBEHB#1+R34-#L;V8`23P)(^WID@$US][=SV
M-WXNN[9]DT,$#(V,X(C..*ZJWMX;2VCMK>,1Q1*$1!T4#H*@ETNQF^U>9;(W
MVQ0MQG/[P`8`/X4$QG%2;MI_P3-MKB^M]?LK&XO6N$GM)9GW(JY8,F`,#H`3
M6>-6U:73EN@+B>W6ZN8YWM%0RHJN0A`/4#'..>E=%=Z797S0M<P;F@SY3!BK
M)G@X((.#Z5&NAZ:D*0QVPCC0N0L;LH^;ENAYS18I3AU7]:F5HCBZ\3:A=1WD
MLL+VEJZ9P%8,K$'&./7\:Z2JR:;9Q7@NXH!',(Q%N0D`H.@('!QDX]*LT(SG
M)2=T%%%%,@****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
8H`****`"BBB@`HHHH`****`"BBB@#__9
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
